GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
The core of this legal dispute often centers on the 340B program, a federal initiative...
The core of this legal dispute often centers on the 340B program, a federal initiative...
In a move that significantly broadens the White House’s ongoing efforts to overhaul the American...
The landscape of headache medicine has undergone a seismic shift over the last decade, transitioning...
The central conflict revolves around Enbrel, Amgen’s blockbuster treatment for rheumatoid arthritis and psoriasis, which...
The narrative of messenger RNA (mRNA) technology has undergone one of the most dramatic transformations...
Louise Emmett, a preeminent figure in the rapidly evolving field of nuclear medicine, is issuing...
However, Alnylam Pharmaceuticals is now aggressively pushing back against this narrative. In a series of...
The Food and Drug Administration on Friday approved a new treatment for a rare and...
Beatrice, whose name has been changed to protect her privacy, recently sat in an examination...
One year after their high-profile departure from the nation’s leading public health agency, three former...